参考文献 References
[1] Alfaddagh A, Martin S S, Leucker T M, et al. Inflammation and cardiovascular disease: From mechanisms to therapeutics[J]. American journal of preventive cardiology, 2020, 4: 100130.
[2] Li G, Yang L, Feng L, et al. Syringaresinol protects against type 1 diabetic cardiomyopathy by alleviating inflammation responses, cardiac fibrosis, and oxidative stress[J]. Molecular nutrition & food research, 2020, 64(18): 2000231.
[3] Yu Y, Yan Y, Niu F, et al. Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases[J]. Cell death discovery, 2021, 7(1): 193.
[4] Emran T, Chowdhury N I, Sarker M, et al. L-carnitine protects cardiac damage by reducing oxidative stress and inflammatory response via inhibition of tumor necrosis factor-alpha and interleukin-1beta against isoproterenol-induced myocardial infarction[J]. Biomedicine & Pharmacotherapy, 2021, 143: 112139.
[5] Liberale L, Montecucco F, Tardif J C, et al. Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease[J]. European heart journal, 2020, 41(31): 2974-2982.
[6] Amin M N, Siddiqui S A, Ibrahim M, et al. Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer[J]. SAGE open Medicine, 2020, 8: 2050312120965752.
[7] Wang Q, Wu J, Zeng Y, et al. Pyroptosis: a pro-inflammatory type of cell death in cardiovascular disease[J]. Clinica chimica acta, 2020, 510: 62-72.
[8] Koushki K, Shahbaz S K, Mashayekhi K, et al. Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways[J]. Clinical reviews in allergy & immunology, 2021, 60: 175-199.
[9] Priyamvara A, Dey A K, Bandyopadhyay D, et al. Periodontal inflammation and the risk of cardiovascular disease[J]. Current atherosclerosis reports, 2020, 22: 1-6.
[10] Wang G, Chen J J, Deng W Y, et al. CTRP12 ameliorates atherosclerosis by promoting cholesterol efflux and inhibiting inflammatory response via the miR-155-5p/LXRα pathway[J]. Cell death & disease, 2021, 12(3): 254.
[11] Gunawardana H, Romero T, Yao N, et al. Tissue-specific endothelial cell heterogeneity contributes to unequal inflammatory responses[J]. Scientific reports, 2021, 11(1): 1949.
[12] 杨青卓,吴辉,刘滴,等.cGAS-STING信号通路介导的炎症反应在心血管疾病中作用及机制研究进展[J].中国分子心脏病学杂志, 2023, 23(4):5577-5582.
[13] 木胡牙提.心血管疾病的新视角:从炎症反应到风险预测[J].新疆医科大学学报, 2025, 48(1):1.
[14] 高凡雅,王军奎,张?,等.细胞焦亡在心血管系统疾病中的研究进展[J].世界最新医学信息文摘, 2021.
[15] 菅传敏,刘 松,高 娟,等.PCSK9抑制剂对超高危ASCVD合并CKD患者系统免疫炎症指数变化及心血管风险的影响[J].临床医学进展, 2025, 15(3):10.
[16] 都昌乐,王瑜,梅仁彪.共刺激信号与心血管疾病的研究进展[J].中国免疫学杂志, 2024, 40(3):656-662.
[17] 黄纬凌,杨俊,杨简.NLRP3介导炎症反应在心血管疾病中的研究进展[J].中国老年学杂志, 2016(24).
[18] 吴晓丹,黄建浩,李善群,等.慢性间歇性缺氧大鼠炎症反应和心血管功能变化[C]//中华医学会全国呼吸病学术会议.2010.
[19] 陈琪.代谢性炎症反应与心血管功能调控[C]//第14届中国南方国际心血管病学术会议(南方会).0[2025-06-22].